In a new study, Ozempic-maker Novo Nordisk shows that its weight loss pill could achieve the similar efficacy as injectables. Novo Nordisk's Chief Scientific Officer says they're expecting FDA approval for the daily pill this year. NBC News' Emilie Ikeda has the story.

See Full Page